SEARCH

SEARCH BY CITATION

References

  • Akama K. T. & Van Eldik L. J. (2000) Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J. Biol. Chem. 275, 79187924.
  • Akama K. T., Albanese C., Pestell R. G. & Van Eldik L. J. (1998) Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc. Natl Acad. Sci. USA 95, 57955800.DOI: 10.1073/pnas.95.10.5795
  • Alzheimer's Disease Collaborative Group. (1995) The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nature Genet. 11, 219222.
  • Bruce A. J., Malfroy B. & Baudry M. (1996) Beta-amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl Acad. Sci. USA 93, 23122316.DOI: 10.1073/pnas.93.6.2312
  • Canevari L., Clark J. B. & Bates T. E. (1999) Beta-amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 457, 131134.DOI: 10.1016/s0014-5793(99)01028-5
  • Cassarino D. S., Parks J. K., Parker W. D. & Bennett J. P. (1999) The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Acta 1453, 4962.
  • Combs C. K., Johnson D. E., Cannady S. B., Lehman T. M. & Landreth G. E. (1999) Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J. Neurosci. 19, 928939.
  • Diana A., Eriksson C., Winblad B. & Schultzberg M. (2000) IL-1beta and ICE mRNA are not altered upon beta-amyloid (25–35) induced neurotoxicity in human neuroblastoma cells. Int J. Dev Neurosci. 18, 237246.DOI: 10.1016/s0736-5748(99)00092-1
  • Dikalov S. I., Vitek M. P., Maples K. R. & Mason R. P. (1999) Amyloid beta peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides. J. Biol. Chem. 274, 9399.
  • Goate A., Chartier-Harlin M. C. & Mullan M. et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704706.
  • Hardy J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurol. Sci. 20, 154159.
  • Hussain I., Powell D., Howlett D. R., Tew D. G., Meek T. D., Chapman C., Gloger I. S., Murphy K. E., Southan C. D., Ryan D. M., Smith T. S., Simmons D. L., Walsh F. S., Dingwall C. & Christie G. (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 6, 427.
  • Iwatsubo T., Okada A., Suzuki N., Mizusawa H., Nukina N. & Ihara Y. (1994) Visualization of A beta 42 (43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42. Neuron 13, 4553.
  • Kaur H., Whiteman M. & Halliwell B. (1997) Peroxynitrite-dependent aromatic hydroxylation and nitration of salicylate and phenylalanine. Is hydroxyl radical involved? Free Rad. Res. 26, 7182.
  • Khan S. M., Cassarino D. S., Abramova N. N., Keeney P. M., Borland M. K., Trimmer P. A., Krebs C. T., Bennett J. C., Parks J. K., Swerdlow R. H., Parker W. D. & Bennett J. P. (2000) Alzheimer's disease cybrids replicate β-amyloid abnormalities through cell death pathways. Ann. Neurol. 48, 148155.
  • Klein A. M., Kowall N. W. & Ferrane R. J. (1999) Neurotoxicity and oxidative damage of beta amyloid 1–42 versus beta amyloid 1–40 in the mouse cerebral cortex. Ann. NY Acad. Sci. 893, 320.
  • Levy-Lahad E., Wijsman E., Nemens E., Anderson L., Goddard K. A., Weber J. L., Bird T. D. & Schellenberg G. D. (1995) A familial Alzheimer's disease locus on chromosome 1. Science 269, 970973.
  • Masliah E., Sisk A., Mallory M., Mucke L., Schenk D. & Games D. (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16, 57955811.
  • McGowan E., Sanders S., Iwatsubo T., Takeuchi A., Saido T., Zehr C., Yu X., Uljon S., Wang R., Mann D., Dickson D. & Duff K. (1999) Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol. Dis. 6, 231244.DOI: 10.1006/nbdi.1999.0243
  • Moechars D., Dewachter I., Lorent K., Reverse D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Haute C. V., Checler F., Godaux E., Cordell B. & Van Leuven F. (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274, 64836492.
  • Narayan M., Berliner L. J., Merola A. J., Diaz P. T. & Clanton T. L. (1997) Biological reactions of peroxynitrite: evidence for an alternative pathway of salicylate hydroxylation. Free Rad. Res. 27, 6372.
  • Noda M., Nakanishi H. & Akaike N. (1999) Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92, 14651474.DOI: 10.1016/s0306-4522(99)00036-6
  • Parker W. D., Parks J. K., Filley C. M. & Kleinschmidt-DeMasters B. K. (1994) Electron transport chain defects in Alzheimer's disease brain. Neurology 44, 10901096.
  • Puttfarcken P. S., Manelli A. M., Neilly J. & Frail D. E. (1996) Inhibition of age-induced beta-amyloid neurotoxicity in rat hippocampal cells. Exp. Neurol. 138, 7381.DOI: 10.1006/exnr.1996.0048
  • Rossi F. & Bianchini E. (1996) Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes. Biochem. Biophys. Res. Commun. 225, 474478.DOI: 10.1006/bbrc.1996.1197
  • Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D. & Younkin S. (1995) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864870.
  • Sheehan J. P., Swerdlow R. H., Miller S. W., Davis R. E., Parker W. D. & Tuttle J. B. (1997) Altered calcium homeostasis and reactive oxygen species in cells transformed by mitochondrial DNA from individuals with sporadic Alzheimer's disease. J. Neurosci. 17, 46124622.
  • Sherrington R., Rogaev E. I. & Liang Y. et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754760.
  • Sinha S., Anderson J. P. & Barbour R. et al. (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537540.DOI: 10.1038/990114
  • Smith M. A., Harris P. L. R., Sayre L. M., Beckman J. S. & Perry G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17, 26532657.
  • Smith M. A., Hirai K., Hsiao K., Papolla M. A., Harris P. L. R., Siedlak S. L., Tabaton M. & Perry G. (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70, 22122215.
  • Swerdlow R. H., Parks J. K., Cassarino D. S., Maguire D. J., Maguire R. S., Bennett J. P., Davis R. E. & Parker W. D. (1997) Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 49, 918925.
  • Vassar R., Bennett B. D., Babu-Khan S., Khan S., Mendiaz E. A., Dennis P., Teplow D. B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M. A., Biere A. L., Curran E., Burgess T., Louis J. C., Collins F., Treanor J., Rogers G. & Citron M. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735741.DOI: 10.1126/science.286.5440.735
  • Wang J., Dickson D. W., Trojanowski J. Q. & Lee V. M. (1999) The levels of soluble versus insolube brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp. Neurol. 158, 328337.DOI: 10.1006/exnr.1999.7085
  • Wei H., Leeds P. R., Qian Y., Wei W., Chen R. & Chuang D. (2000) beta-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment. Eur. J. Pharmacol. 392, 123.
  • Yan R., Bienkowski M. J., Shuck M. E., Miao H., Tory M. C., Pauley A. M., Brashier J. R., Stratman N. C., Mathews W. R., Buhl A. E., Carter D. B., Tomaselli A. G., Parodi L. A., Heinrikson R. L. & Gurney M. E. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533537.DOI: 10.1038/990107
  • Yatin S. M., Varadarajan S., Link C. D. & Butterfield D. A. (1999) In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1–42). Neurobiol. Aging 20, 325330.DOI: 10.1016/s0197-4580(99)00056-1